BioStem Technologies Inc. to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House

September 19, 2018

Pompano Beach, FL, September 19th, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and Regenerative Medicine...

Read More

Nesvik Pharmaceuticals, Inc., a Subsidiary of BioStem Technologies, Inc., Announces Engagement of The Gnomon Group for Pre-Investigational New Drug Application Strategy

September 17, 2018

Pompano Beach, FL, Sept. 17, 2018 (GLOBE NEWSWIRE) - Nesvik Pharmaceuticals, Inc., a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), focused on the development of novel reformulated pharmaceutical products that addre...

Read More
Please reload

Featured Posts

BioStem Technologies Releases Third Quarter 2018 Shareholder Update

December 10, 2018

1/2
Please reload

Recent Posts

BioStem Technologies Releases Third Quarter 2018 Shareholder Update

December 10, 2018

BioStem Technologies Selects PCG Advisory Group for Investor Relations and Strategic Communications

October 17, 2018

BioStem Life Sciences, Inc., Subsidiary of BioStem Technologies, Inc., Announces Entry into Market with Four Amniotic Products

October 1, 2018

BioStem Technologies Inc. to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House

September 19, 2018

Nesvik Pharmaceuticals, Inc., a Subsidiary of BioStem Technologies, Inc., Announces Engagement of The Gnomon Group for Pre-Investigational New Drug Ap...

September 17, 2018

Nesvik Pharmaceuticals, Inc., Receives Updated U.S. FDA Establishment Registration in Light of New Product Development

August 28, 2018

BioStem Technologies, Inc. Completes 2016, 2017 Audit of Financial Statements

August 17, 2018

BioStem Technologies, Inc. Engages Maxim Group LLC For Strategic Advisory Services

August 15, 2018

BioStem Technologies, Inc. (BSEM) Launches New Subsidiary to Engage in the Processing and Supply of Regenerative Tissue Products

August 9, 2018

BioStem Technologies Inc. Launches Expanded Shareholder Communications Initiative

August 8, 2018

Please reload

Archive

December 2018 (1)

October 2018 (2)

September 2018 (2)

August 2018 (5)

July 2018 (1)

June 2018 (1)

April 2018 (1)